Genmab, a biotech company, has partnered with OpenAI to use the ChatGPT Enterprise platform. This partnership allows Genmab to leverage AI technology across its operations. OpenAI's commitment to security and privacy is cited as a key factor in this decision. --- Why it matters: This matters to researchers because it demonstrates another major industry adopting AI technology, potentially paving the way for more widespread adoption in similar fields. Source: https://openai.com/index/genmab